Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study.
about
Amyotrophic lateral sclerosis: considerations on diagnostic criteriaImmunosuppressant and immunomodulatory treatments for multifocal motor neuropathyImmunosuppressant and immunomodulatory treatments for multifocal motor neuropathyImmunosuppressant and immunomodulatory treatments for multifocal motor neuropathyIntravenous immunoglobulin for multifocal motor neuropathySystematic reviews of treatment for inflammatory demyelinating neuropathyRapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodiesOffice immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathyMultifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variantsLong term follow up of multifocal motor neuropathy with conduction block under treatment.Motor neuron disease--a review.Diagnosis of motor neuropathy.Intravenous immunoglobulin in neurological disease: a specialist review.Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies.Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies.Use of human intravenous immunoglobulin in lower motor neuron syndromesThe effect of treatment upon temporal dispersion in IvIg responsive multifocal motor neuropathyA practical definition of conduction block in IvIg responsive multifocal motor neuropathyThe pathogenesis of multifocal motor neuropathy and an update on current management options.Axon loss is an important determinant of weakness in multifocal motor neuropathy.Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy.Single fibre electromyography in multifocal motor neuropathy with persistent conduction blocksImmunotherapy in Peripheral NeuropathiesPredicting treatment response in chronic, acquired demyelinating neuropathies.Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registryEvidence-based treatment of chronic immune-mediated neuropathies.Plasmapheresis for neurological disorders.Subcutaneous immunoglobulin: opportunities and outlook.Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatmentImmunotherapy of multifocal motor neuropathy.Activity-dependent conduction failure: molecular insights.Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.Multifocal motor neuropathy: current therapies and novel strategies.Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects.The expanding role of therapeutic antibodies.Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach.10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.Rasch-built Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS(©) ).High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance.
P2860
Q22305918-3F205BF9-2DAF-48B1-BDE8-A01B87F109EBQ24187418-E05C76BB-AB07-43B6-A717-1674C030E7D0Q24200228-DF6B1034-24A7-40F5-BC2D-9BE65591B576Q24241391-FF6FB82B-8364-413C-BDA0-F6B0948E9FB9Q24247007-95694E47-6D31-4FCA-8FBA-9C3245E8E8DCQ24676037-E5F5E75B-02A0-4587-A559-D925A160E6A7Q26864907-F23CD87F-B119-4954-AD38-01FD10E66353Q28081570-4094CA93-2D4D-479C-BD41-A05EFD251EADQ28390264-7ACEDFB4-851A-4DCF-9621-72ECF04720C5Q33735714-2AB29C27-EC97-45F9-A1AE-F332D41905C0Q33892039-260C6144-D30C-4114-8CC6-7B6B399D7674Q34235867-0675305B-2A75-4A5B-9849-63561BD8FB6FQ34574581-1C6FD205-6CE5-4684-B026-383EC446168FQ34620111-C130D927-F425-4D6B-9D23-743EB2B180F5Q35294158-5B3A006D-84E1-48B8-B03D-0E1FB872930BQ35449950-98DD7A35-8EC2-4F4C-A262-5A61F101EA91Q35452109-B796122D-E52D-46F0-8E1B-DBAC2815C9B1Q35489630-5CFBFE84-C3B2-43A6-9569-228AE1805918Q35489932-E431A262-1770-46FC-8448-E7ACBFBAEDF8Q35537340-181D902F-C59C-437C-BB8E-57760E46B069Q36142106-3977AF08-A907-475F-84AE-821DCF3DE04EQ36317538-0E4B9DDA-3E4B-4A26-9FC3-A62AE5014553Q36318744-C395C404-EFD9-4E87-8A53-2E617A38CE44Q36484418-4AD6D488-68B4-4E2B-B0E9-C2D068EA17B4Q36641529-CA966354-9F79-4CC8-B010-186F4656F51AQ36737563-6163F162-1C96-40F3-B342-BAAA201961F4Q37550515-44290E18-2680-4DCA-9C88-41AFCC9C18BAQ37600865-9F69CB7C-5B3D-4685-9ACF-09FAFA43EF20Q37626132-308A466C-B626-4A8F-8342-F25B8F529F98Q37696931-8AEB0175-07D7-418A-86C5-98DFB1C5113EQ37836898-413240B1-0860-4338-A646-07D371A42BA6Q37946413-31D7AC9C-9A9F-4C1B-B68F-31DFF26D48FFQ37959252-0C4787EC-DB48-4C3B-93A0-5C7E0E84527BQ38091664-06263D26-61C5-44DF-A484-9628ED809738Q38152428-23BD8996-DDA8-4BFB-87B6-A48FF115F431Q38182645-4E15FD04-3FA3-4987-B900-52D2925D4A16Q38270717-E436DA85-04BE-4A9C-B954-52411BA81B6AQ38820352-F04551EB-6B30-4799-A3FB-3C5C8C6EF9E8Q38968456-A054B149-0A28-4F9D-9831-8BF3159B64EEQ39604919-AAFDC556-19DA-4F54-A977-59FDAD358AAE
P2860
Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Treatment of multifocal motor ...... ind, placebo controlled study.
@en
type
label
Treatment of multifocal motor ...... ind, placebo controlled study.
@en
prefLabel
Treatment of multifocal motor ...... ind, placebo controlled study.
@en
P2093
P2860
P356
P1476
Treatment of multifocal motor ...... ind, placebo controlled study.
@en
P2093
Franssen H
Jennekens FG
Kerkhoff H
Van den Berg LH
Vermeulen M
P2860
P304
P356
10.1136/JNNP.59.3.248
P407
P577
1995-09-01T00:00:00Z